Elevance Health Inc (ELV)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,120.57 | 1,100.87 | 326.88 | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 9.39 | 9.45 | 9.12 | 8.96 | 9.84 | 10.70 | 10.39 | 10.19 | 8.54 | 8.00 | 7.86 | 6.31 | 7.48 | 6.95 | 6.19 | 7.68 | 6.72 | 6.16 | 6.58 | 6.77 |
Elevance Health Inc's receivables turnover ratio declined from 10.70 in Q3 2022 to 9.53 in Q4 2023, indicating that the company took longer to collect its accounts receivable over time. However, the ratio remained relatively stable within the range of 9.53 to 10.70 throughout the period under consideration.
The working capital turnover ratio decreased gradually from 10.62 in Q3 2022 to 9.33 in Q4 2023. This downward trend suggests that Elevance Health Inc's ability to generate revenue from its working capital has declined over the period, possibly indicating inefficiencies in managing its working capital resources.
Unfortunately, data on inventory turnover and payables turnover ratios are missing, limiting a comprehensive analysis of Elevance Health Inc's activity ratios.
Average number of days
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.33 | 0.33 | 1.12 | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Days of Inventory on Hand (DOH) is not provided in the table, so we are unable to analyze the inventory turnover for Elevance Health Inc.
Days of Sales Outstanding (DSO) measures how long it takes for the company to collect payment after making a sale. In Q4 2023, DSO increased to 38.31 days from 36.91 days in Q3 2023, indicating that it took longer for Elevance Health Inc to collect payments from its customers during this period. However, compared to the same quarter in the previous year (Q4 2022), the DSO has increased from 37.62 days to 38.31 days.
Number of Days of Payables is not provided in the table, which limits our ability to analyze the efficiency of the company's payables management.
Overall, based on the information available, the DSO for Elevance Health Inc has been fluctuating but slightly increasing over time, indicating potential issues with collections efficiency. This trend should be monitored closely to ensure timely cash flow management and liquidity for the company.
See also:
Elevance Health Inc Short-term (Operating) Activity Ratios (Quarterly Data)
Long-term
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | 39.31 | 39.69 | 36.44 | 36.37 | 36.28 | 36.51 | 36.46 | 36.21 | 35.38 | 34.91 | 34.62 | 35.28 | 34.99 | 34.92 | 32.96 | 32.59 | 33.26 | 34.30 | 34.11 | 33.67 |
| Total asset turnover | 1.57 | 1.53 | 1.52 | 1.47 | 1.52 | 1.49 | 1.48 | 1.44 | 1.42 | 1.37 | 1.34 | 1.30 | 1.41 | 1.36 | 1.28 | 1.32 | 1.35 | 1.29 | 1.28 | 1.26 |
The long-term activity ratios of Elevance Health Inc indicate how effectively the company is utilizing its assets to generate revenue.
1. Fixed asset turnover: The fixed asset turnover ratio measures how efficiently the company is using its fixed assets to generate sales revenue. A higher fixed asset turnover ratio signifies that the company is generating more revenue per dollar invested in fixed assets. Elevance Health Inc has maintained a high and consistent fixed asset turnover ratio over the quarters, ranging from 35.81 to 39.41. This indicates that the company is effectively utilizing its fixed assets to generate sales.
2. Total asset turnover: The total asset turnover ratio measures how efficiently the company is using all its assets to generate sales. A higher total asset turnover ratio indicates that the company is generating more revenue per dollar invested in total assets. Elevance Health Inc has shown a stable total asset turnover ratio, ranging from 1.42 to 1.56. This suggests that the company is efficiently utilizing its total assets to generate revenue consistently across the quarters.
Overall, the analysis of Elevance Health Inc's long-term activity ratios reveals that the company is effectively managing its assets to generate revenue, as indicated by high and stable fixed asset turnover and total asset turnover ratios.
See also:
Elevance Health Inc Long-term (Investment) Activity Ratios (Quarterly Data)